carbidopa has been researched along with Necrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manno, RA; Maronpot, RR; Nyska, A; Ramot, Y; Sacco, G; Shaltiel-Karyo, R; Tsarfati, Y; Yacoby-Zeevi, O | 1 |
| Eskey, CJ; Gardner, TB; Lewis, LD; Nierenberg, DW; Osterling, W; Reddy, NJ | 1 |
2 other study(ies) available for carbidopa and Necrosis
| Article | Year |
|---|---|
Ninety-day Local Tolerability and Toxicity Study of ND0612, a Novel Formulation of Levodopa/Carbidopa, Administered by Subcutaneous Continuous Infusion in Minipigs.
Topics: Animals; Carbidopa; Dopamine Agonists; Drug Combinations; Drug Evaluation, Preclinical; Drug Tolerance; Female; Infusions, Subcutaneous; Injection Site Reaction; Levodopa; Male; Necrosis; Swine; Swine, Miniature; Toxicity Tests, Chronic | 2017 |
Two cases of rapid onset Parkinson's syndrome following toxic ingestion of ethylene glycol and methanol.
Topics: Acute Disease; Adult; Aged; Antiparkinson Agents; Basal Ganglia; Carbidopa; Ethylene Glycol; Female; Humans; Levodopa; Male; Methanol; Necrosis; Parkinson Disease, Secondary; Respiratory Insufficiency; Tomography, X-Ray Computed | 2007 |